| abstract |
The present invention utilizes antisense nucleotides or siRNAs to inhibit the expression of apoptosis specific eukaryotic initiation factor 5A (eIF-5A), apoptosis factor 5A1 nucleic acids and polypeptides and factor 5A1, designated apoptosis factor 5A1 or simply factor 5A1. To inhibit or inhibit intracellular apoptosis. The present invention also relates to inhibiting or inhibiting the expression of pro-inflammatory cytokines by inhibiting the expression of apoptosis factor 5A. |